DOI : 10.1055/s-00000054

Pharmacopsychiatry

Issue 06 · Volume 21 · December 2011 DOI: 10.1055/s-002-22322

  • A1
  • A2
  • A3
    Klampfl, K; Fleischmann, Y; Wewetzer, Ch; Pfuhlmann, B; Mehler-Wex, C; Gerlach, M:

    Therapeutic drug monitoring (TDM) in children and adolescents during sertraline therapy

  • A4
  • A5
  • A6
  • A7
  • A8
    Mercolini, L; Mandrioli, R; Ferranti, A; Amore, M; Raggi, MA:

    Therapeutic drug monitoring of the recent antidepressant duloxetine: method comparison

  • A9
  • A10
  • A11
    Ostad Haji, E; Tadić, A; Dragicevic, A; Müller, MJ; Grasmäder, K; Rao, ML; Laux, G; Hiemke, C:

    Plasma concentrations of citalopram in inpatients with acute major depression are predictive for later non-response. Data from an observational study

  • A12
  • A13
    Lutz, UC; Hiemke, C; Wiatr, G; Farger, G; Arand, J; Wildgruber, D:

    Aripiprazole use during pregnancy and lactation

  • A14
  • A15
  • A16
    Raggi, MA; Mandrioli, R; Bugamelli, F; Mercolini, L; Saracino, MA; Marcheselli, C; Morganti, E:

    Plasma monitoring: a challenge for and of the laboratory

  • A17
    Unterecker, S; Pfuhlmann, B; Hiemke, C; Greiner, C; Haen, E; Jabs, B; Kruggel-Bachmann, S; Deckert, J:

    Additive effects of sex, age and smoking on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions

  • A18
    Hader, A; Beck, S; Jahner, T; Melchner, D; Haen, E:

    Identification of a slow CYP3A4 metabolizer by TDM – a case report

  • A19
    Mandrioli, R; Mercolini, L; Ghedini, N; Amore, M; Kenndler, E; Raggi, MA:

    Comparison of CE and HPLC for therapeutic drug monitoring of the antiepileptic drug topiramate

  • A20
  • A21
    Mercolini, L; Fulgenzi, G; Melis, M; Boncompagni, G; Albers, LJ; Raggi, MA:

    Therapeutic drug monitoring (TDM) of the recent antipsychotic ziprasidone in dried blood spots (DBS) and plasma

  • A22